0000746838-21-000031.txt : 20210302
0000746838-21-000031.hdr.sgml : 20210302
20210302164914
ACCESSION NUMBER: 0000746838-21-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210226
FILED AS OF DATE: 20210302
DATE AS OF CHANGE: 20210302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Madion Lisa
CENTRAL INDEX KEY: 0001838400
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08729
FILM NUMBER: 21704585
BUSINESS ADDRESS:
BUSINESS PHONE: 267-462-2095
MAIL ADDRESS:
STREET 1: 801 LAKEVIEW DRIVE
STREET 2: SUITE 100
CITY: BLUE BELL
STATE: PA
ZIP: 19422
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNISYS CORP
CENTRAL INDEX KEY: 0000746838
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
IRS NUMBER: 380387840
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 801 LAKEVIEW DRIVE, SUITE 100
CITY: BLUE BELL
STATE: PA
ZIP: 19422
BUSINESS PHONE: 2159864011
MAIL ADDRESS:
STREET 1: 801 LAKEVIEW DRIVE, SUITE 100
CITY: BLUE BELL
STATE: PA
ZIP: 19422
FORMER COMPANY:
FORMER CONFORMED NAME: BURROUGHS CORP /DE/
DATE OF NAME CHANGE: 19861204
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-02-26
0
0000746838
UNISYS CORP
UIS
0001838400
Madion Lisa
801 LAKEVIEW DRIVE
SUITE 100
BLUE BELL
PA
19422
0
1
0
0
Senior Vice President
Common Stock
2021-02-26
4
M
0
622
0
A
12890
D
Common Stock
2021-02-26
4
F
0
210
24.55
D
12680
D
Common Stock
2021-02-26
4
M
0
976
0
A
13656
D
Common Stock
2021-02-26
4
F
0
330
24.55
D
13326
D
Restricted Stock Units
2021-02-26
4
M
0
622
0
D
Common Stock
622
1244
D
Restricted Stock Units
2021-02-26
4
M
0
622
0
D
Common Stock
976
0
D
Restricted Stock Units
2021-02-26
4
A
0
4074
0
A
Common Stock
4074
4074
D
Restricted Stock Units
2021-02-26
4
A
0
4549
0
A
Common Stock
4549
4549
D
Restricted Stock Units
2021-02-26
4
A
0
9098
0
A
Common Stock
9098
9098
D
Each restricted stock unit represents a contingent right to receive one share of Unisys Corporation common stock.
Time-based restricted stock units ("TB-RSUs") granted on February 28, 2020 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on February 28, 2021, 2022 and 2023, respectively (or if such date does not fall on a trading day, the immediately preceding trading day).
Each restricted stock unit represents a contingent right to receive 1.5681 shares of Unisys Corporation common stock.
Performance-based restricted stock units ("PB-RSUs") granted on February 28, 2020 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The PB-RSUs are eligible to be earned in equal annual amounts over a three year period based on Unisys Corporation's relative total shareholder return compared to the Russell 2000 Index from January 1, 2020 through December 31, 2020, 2021 and 2022, respectively, and then such PB-RSUs vest on the later of February 28, 2021, 2022 and 2023, respectively (or if such date does not fall on a trading day, the immediately preceding trading day), and the date on which the Board of Directors verifies the vesting of the applicable tranche of the PB-RSU grant to Unisys Corporation's Chief Executive Officer. This report only relates to the PB-RSUs the reporting person earned during the 2020 performance period. All shares resulting from such earned PB-RSUs vested on February 26, 2021.
Each restricted stock unit represents a contingent right to receive one share of Unisys Corporation common stock.
Time-based restricted stock units ("TB-RSUs") granted on February 26, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest in three equal installments on February 26, 2022, 2023 and 2024, respectively (or if such date does not fall on a trading day, the immediately preceding trading day).
Each restricted stock unit represents a contingent right to receive one share of Unisys Corporation common stock.
Time-based restricted stock units ("TB-RSUs") granted on February 26, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The TB-RSUs vest on February 26, 2024.
Each restricted stock unit represents a contingent right to receive up to one share of Unisys Corporation common stock.
Performance-based restricted stock units ("PB-RSUs") granted on February 26, 2021 under the Unisys Corporation 2019 Long-Term Incentive and Equity Compensation Plan. The PB-RSUs will be eligible to vest at a conversion rate of between 0.5 shares to 1 share of Unisys Corporation common stock for each PB-RSU if the 20-trading day trailing average of the closing price of Unisys Corporation's common stock over any 20 consecutive trading days during the period from the grant date through February 26, 2024 is 10% to 20% higher (with the conversion rate determined by linear interpolation for increases between such range) than the closing price of Unisys Corporation's common stock on the grant date. If the stock price appreciation test is not met at least at the 10% level, then the PB-RSUs will not vest at all. If the stock price appreciation test is met at greater than the 20% level, then the PB-RSUs will vest at the rate of 1 share of Unisys Corporation common stock for each PB-RSU.
John M. Armbruster, attorney-in-fact
2021-03-02
EX-24
2
madion.txt
POWER OF ATTORNEY
FOR EXECUTING FORMS 3, 4 and 5
Know all by these presents, that the undersigned hereby constitutes and appoints
each of Gerald P. Kenney, John M. Armbruster, and N. Natasha Redding,
signing singly, his/her true and lawful attorney-in-fact, in regard to ownership
of securities for Unisys Corporation (the "Company"), to:
(1) execute for and on behalf of the undersigned Forms 3, 4 and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934 and the rules
thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete the execution of any such Form 3, 4
or 5 and the timely filing of such form with the United States Securities and
Exchange Commission and any other authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve
in his/her discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as such attorney-in-fact
might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
his/her substitute or substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and rights and powers herein granted. The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are not assuming any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5, with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 21st day of December, 2020.
/s/ Lisa Madion
Signature
Lisa Madion
Print Name